Bbva Compass Bancshares Inc. lifted its position in shares of Envision Healthcare Corporation (NYSE:EVHC) by 25.0% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 9,033 shares of the company’s stock after purchasing an additional 1,804 shares during the quarter. Bbva Compass Bancshares Inc.’s holdings in Envision Healthcare Corporation were worth $406,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors also recently bought and sold shares of EVHC. Janus Henderson Group PLC lifted its position in shares of Envision Healthcare Corporation by 36,086.8% during the 2nd quarter. Janus Henderson Group PLC now owns 3,945,087 shares of the company’s stock worth $247,239,000 after buying an additional 3,934,185 shares during the period. Maverick Capital Ltd. lifted its position in shares of Envision Healthcare Corporation by 66.2% during the 2nd quarter. Maverick Capital Ltd. now owns 5,093,292 shares of the company’s stock worth $319,197,000 after buying an additional 2,028,026 shares during the period. Lord Abbett & CO. LLC lifted its position in shares of Envision Healthcare Corporation by 259.6% during the 2nd quarter. Lord Abbett & CO. LLC now owns 1,321,328 shares of the company’s stock worth $82,808,000 after buying an additional 953,928 shares during the period. Westfield Capital Management Co. LP bought a new position in shares of Envision Healthcare Corporation during the 2nd quarter worth approximately $45,892,000. Finally, American Century Companies Inc. bought a new position in shares of Envision Healthcare Corporation during the 2nd quarter worth approximately $31,861,000.

Envision Healthcare Corporation (NYSE:EVHC) opened at $27.04 on Monday. The company has a debt-to-equity ratio of 0.89, a current ratio of 3.01 and a quick ratio of 3.00. Envision Healthcare Corporation has a 52-week low of $26.56 and a 52-week high of $74.75. The stock has a market capitalization of $3,267.14, a price-to-earnings ratio of 8.35, a price-to-earnings-growth ratio of 0.58 and a beta of 0.69.

Envision Healthcare Corporation (NYSE:EVHC) last released its earnings results on Tuesday, October 31st. The company reported $0.73 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.81 by ($0.08). The firm had revenue of $1.99 billion during the quarter, compared to analyst estimates of $2.03 billion. Envision Healthcare Corporation had a negative net margin of 6.39% and a positive return on equity of 4.88%. The firm’s quarterly revenue was up 142.0% on a year-over-year basis. During the same period last year, the business posted $1.13 earnings per share. equities research analysts expect that Envision Healthcare Corporation will post 3.12 earnings per share for the current year.

Envision Healthcare Corporation announced that its board has approved a stock buyback plan on Monday, September 18th that permits the company to repurchase $250.00 million in shares. This repurchase authorization permits the company to purchase up to 4.5% of its shares through open market purchases. Shares repurchase plans are often a sign that the company’s board believes its shares are undervalued.

COPYRIGHT VIOLATION WARNING: “Bbva Compass Bancshares Inc. Purchases 1,804 Shares of Envision Healthcare Corporation (EVHC)” was originally posted by Watch List News and is the sole property of of Watch List News. If you are accessing this story on another publication, it was illegally copied and republished in violation of U.S. & international trademark and copyright legislation. The correct version of this story can be viewed at https://www.watchlistnews.com/bbva-compass-bancshares-inc-purchases-1804-shares-of-envision-healthcare-corporation-evhc/1682959.html.

EVHC has been the subject of several analyst reports. Jefferies Group LLC set a $71.00 target price on Envision Healthcare Corporation and gave the stock a “buy” rating in a research report on Wednesday, November 1st. Bank of America Corporation cut their target price on Envision Healthcare Corporation from $72.00 to $60.00 and set a “buy” rating for the company in a research report on Monday, October 9th. SunTrust Banks, Inc. set a $55.00 target price on Envision Healthcare Corporation and gave the stock a “buy” rating in a research report on Sunday, October 15th. Cantor Fitzgerald restated a “buy” rating on shares of Envision Healthcare Corporation in a research report on Monday, July 24th. Finally, Robert W. Baird restated a “buy” rating and set a $70.00 target price on shares of Envision Healthcare Corporation in a research report on Tuesday, October 17th. Two investment analysts have rated the stock with a sell rating, five have issued a hold rating, ten have issued a buy rating and one has given a strong buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average price target of $49.21.

Envision Healthcare Corporation Profile

Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.

Institutional Ownership by Quarter for Envision Healthcare Corporation (NYSE:EVHC)

Receive News & Ratings for Envision Healthcare Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.